Insights from Day Three of the BIO International Convention in San Diego: https://ow.ly/IrAp50SkhrX. Included in this installment of Scrip’s daily notebook of noteworthy intelligence from the BIO International Convention: • Amgen CEO Bob Bradway taking aim at the "Innovation Reduction Act" • Novo Nordisk's business development head discussing spending its semaglutide bounty • Roivant Sciences's long view on BD prospects for Immunovant's FcRn inhibitor • More regulatory concerns around artificial intelligence #ArtificialIntelligence #InnovationReductionAct #Pharma #Biotech #BIOInternationalConvention
Citeline Commercial’s Post
More Relevant Posts
-
Chief Commercial Officer (CCO) and co-founder of Peregrion | Principal Business Developer TNO Efficient Drug Development. Preclinical/Clinical DMPK/ADME
Attended the PBSS workshop on Human #MassBalance and #MetaboliteProfiling Studies in San Francisco yesterday. Interesting talks by experts from Industry and #FDA. The workshop perfectly covered the strategies, technical approaches (including microtracer AMS), regulatory guidance, applications and case studies. The event was organized by Chandra Prakash, chaired by Shichang Miao and ended with a vibrant Panel Discussion. Thanks to all the speakers: Chandra Prakash (Agios Pharmaceuticals), Bernard Murray (Gilead Sciences), Shuai Wang (Genentech), Ronald Kong (PTC Therapeutics, Inc.), Grace Yan Danielsen (FDA), Ryan Takahashi (Stealth NewCo) and Raman Sharma (Pfizer). #TNO #Peregrion #DMPK #ADME #Bioavailability #MetID #Pharmacokinetics #Bioanalysis #DrugDevelopment.
To view or add a comment, sign in
-
#WRIB is in full swing and Steve Lowes, Richard Snyder, Sara Brady, Rickerson Felix, MBA, and the rest of the Q2 Team are excited to meet with you and talk about your upcoming plans and/or help you overcome scientific, quality, deliverables, or other challenges. Want to set up a time to meet here at WRIB, or if you’re not attending and want to chat, just click here: https://lnkd.in/eRPJS6Uz #drugmetabolism #pharmacokinetics #lifescience #invitro #biotransformation #dmpk #pharma #biotech #research #drugdevelopment #bioanalysis #bioanalytical #immunoassay #lcmsms #lcms #hrms #pharma #adme #oligonucleotides #monoclonalantibodies #rnabasedtherapeutics
To view or add a comment, sign in
-
Don’t miss our Principal Scientist, Jing Liu’s poster presentation on Tuesday, May 7th at this year’s #WRIB event in San Antonio. Key learnings from Jing’s presentation will be: • Self-assembling drug XPro159 is challenging for standard ADA format like Bridging or ACE • Presentation of a novel format, ACE-AG, designed to solve the problem • The format mitigated the high background from the self-assembly of the drug and provided excellent sensitivity. It also demonstrated drug tolerance and robustness against endogenous target interference. Want to set up a time to meet at WRIB or if you’re not attending and want to chat, just click here: https://bit.ly/3Uuv6lQ #drugmetabolism #pharmacokinetics #lifescience #invitro #biotransformation #dmpk #pharma #biotech #research #drugdevelopment #bioanalysis #bioanalytical #immunoassay #lcmsms #lcms #hrms #pharma #adme #oligonucleotides #monoclonalantibodies #rnabasedtherapeutics
To view or add a comment, sign in
-
So you’re looking for GenAI use cases in biopharma… … but you missed our webinar. 😞 Don’t worry, we’ve got you covered. 😉 Join our expert AI panel of Alex Jijie | Digitalya OPS, Jessica Ingram | Camino, and Manuel Mitola, MBA on demand. In this free webinar recording, you will learn all about how you can start with GenAI today. Watch here 👉 https://brnw.ch/21wL66H Psst...👂 We had an amazing Q&A session at the end of the webinar! Check out some of the most pressing questions with answers in the comments below. #magnoliadxp #pharma #biotech #biopharma #genai
To view or add a comment, sign in
-
Arctic Bioscience released its Annual Report 2023 earlier today. "2023 was an exiting year for us, and I expect nothing less from 2024. The data read-out expected in H2 2024 will lay the foundation for a clinical phase III program and subsequent commercialization of our HRO350 drug candidate. Combined with the new drug development initiatives and further nutraceutical growth, I believe 2024 very well could be the most exiting year for Arctic Bioscience’s stakeholders to this date.", comments Christer Valderhaug, CEO of Arctic Bioscience, in his letter to the shareholders. Read the highlights below, or visit our website for the full report. #arcticbioscience #annualreport2023
To view or add a comment, sign in
-
We are only 3 days away from DIA 2024! Visit the Vivpro Corp team at booth #1231 for engaging discussions and enjoy freshly made warm churros! Are you attending? Leave us a comment! ⬇ We would love to connect. 😁 #Vivpro #RIA #DIA2024 #MorePowerToYou #BioTech #Pharma #RegulatoryStrategy #RegulatoryAffairs #ClinPharm #AiinPharma
To view or add a comment, sign in
-
The poster sessions at #WRIB were highly popular this year with long lines, so if you didn't get a chance to speak with Jing L. about her presentation on Anti-Drug Antibody (ADA) Assay for XPro1595, a self-assembling trimer: alternatives to standard bridging or ACE approaches, be sure to stop by our booth #24 and speak to Jing. You can always set up time to meet as well by clicking here: https://bit.ly/3Uuv6lQ #drugmetabolism #pharmacokinetics #lifescience #invitro #biotransformation #dmpk #pharma #biotech #research #drugdevelopment #bioanalysis #bioanalytical #immunoassay #lcmsms #lcms #hrms #pharma #adme #oligonucleotides #monoclonalantibodies #rnabasedtherapeutics
To view or add a comment, sign in
-
Not being the tallest myself, I've always held a special place in my heart for the beauty of small things. This might be why Fragment-Based Drug Discovery (FBDD 😍 ) resonates so strongly with me! I'm thrilled to share that Selvita's Project Owner, Aleksandra Bebel, will be participating in the upcoming 9thRSC-BMCS (https://bit.ly/49NNavX). Selvita has a number of exciting FBDD projects where Aleksandra played a key role in X-ray screening of fragments, with my skilled team supporting them with CADD. Our main tools for this work are InfiniSee and SeeSAR (thanks Marcus Gastreich, BioSolveIT), and we're also grateful for the strong support from Selvita's AI Team (kudos to Joerg Wichard and his Team). Whether you're already passionate about FBDD or just curious to learn more, I highly recommend attending the event and connecting with Aleksandra Bebel for a deeper dive into this fascinating field! #drugdiscovery #pharma #biotech #fragmentbased #medicinalchemistry #structuralbiology
Our colleagues are getting ready to participate in the 9th RSC-BMCS Fragment-based Drug Discovery Meeting in Cambridge, the UK! This will be an excellent opportunity to meet with our team: Alicja Małysiak, Aleksandra Bebel, Karol Źrubek, PhD and Alexander Ignatyev, and discover our vast portfolio of services that can support your drug discovery processes. If you would like to catch up with them, feel free to send us an e-mail at sales@selvita.com. #drugdiscovery #pharma #biotech #fragmentbased #medicinalchemistry #structuralbiology
To view or add a comment, sign in
-
Come meet Chad and I to discuss your drug development needs
We’re excited to meet with you at PBSS Vancouver! Whether for conventional therapeutic agents or biotechnology products, our clients have been reaping the benefits of a successful partnership and accelerated drug development services… without increasing risk. Book time with us here: https://lnkd.in/dWZvvuV8 #ClinicalResearch #DrugDevelopment #BioTech Chad Rathlef Sarah Myriam Fleurima
To view or add a comment, sign in
-
Clinical Innovation on Environmental Sustainability and Patient-Centric Sampling / Clinical Innovation Manager, Novartis
Looking forward presenting in 2 weeks, for the first time externally, our work on shipments with clinical samples, their carbon footprint, and how we can reduce (and get savings along!)... The title of that Symposium is "Challenges and Solutions of Sample Management": I believe that a challenge (to come) is how we will operate by 2030 in a context of targeted carbon-neutrality (scopes 1, 2 & 3). I will present there one solution we built, which will help a lot in that direction - among others! #environmental #sustainability #shipments #clinical #samples #Novartis
In the upcoming 4th EU Sample Management Symposium on June 20th in Frankfurt, Germany, industry experts will share key insights on the future of sample management. The morning session will be led by Dr. Patrick R. Merz (BASF), Orkun Ozhelvaci (BioNTech) and Neil Gow (UCB Pharma). The afternoon session will be presented by Xavier Briand and Dr. Luc Alexis Leuthold, both from Novartis. For more information on their talks and the Symposium, and to register, visit https://lnkd.in/ezNG6sv7. #SLAS2024 #SampleManagement #Biotech #Pharma
To view or add a comment, sign in
11,278 followers